The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacogenomic study of gemcitabine on the safety and efficacy in patients with metastatic pancreatic cancer (GENESECT study): Analysis of a subpopulation.
 
Takashi Yokokawa
Speakers' Bureau - AstraZeneca; Janssen; Ono Pharmaceutical
 
Daiki Tsuji
Speakers' Bureau - Taiho Pharmaceutical; Towa Pharmaceutical
 
Masahiro Hatori
No Relationships to Disclose
 
Kenichi Suzuki
No Relationships to Disclose
 
Kazuyoshi Kawakami
Speakers' Bureau - Daiichi Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical
 
Masahiko Nakao
No Relationships to Disclose
 
Takuya Yano
No Relationships to Disclose
 
Yuichiro Arakawa
No Relationships to Disclose
 
Keisuke Matsuo
No Relationships to Disclose
 
Yasukata Ohashi
No Relationships to Disclose
 
Masato Ozaka
Honoraria - AstraZeneca; Bayer; Eisai; MSD; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Naoki Sasahira
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma; Daiichi Sankyo; Shionogi; Taiho Pharmaceutical; Teijin Pharma
 
Yasuhiko Sakata
No Relationships to Disclose
 
Yuki Kogure
Speakers' Bureau - Bristol Myers Squibb Foundation; Daiichi Sankyo; Kyowa Kirin; Pfizer; Taiho Pharmaceutical
 
Shinya Tamaki
No Relationships to Disclose
 
Atsushi Wada
Employment - MediFrame
Leadership - MediFrame
Stock and Other Ownership Interests - MediFrame
Speakers' Bureau - AstraZeneca Japan
Patents, Royalties, Other Intellectual Property - MediFrame Inc.
 
Yusuke Taki
No Relationships to Disclose
 
Hiroshi Ishii
Honoraria - AstraZeneca Japan; Chugai Pharma; Incyte; Lilly Japan; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma
 
Kunihiko Itoh
No Relationships to Disclose
 
Masakazu Yamaguchi
Consulting or Advisory Role - Ono Pharmaceutical
Speakers' Bureau - Abbvie; Bayer; Celltrion; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Shionogi; Sun Pharma; TERUMO; TOWA